RedHill Biopharma Ltd.
RDHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001553846
In the last 90 days, RedHill Biopharma Ltd. insiders filed 0 open-market purchases and 1 sale; 14 institutions reported holding it in 13F filings for Q2 2026, worth $270.0K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in RedHill Biopharma Ltd. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −2 vs. Q4 2023
- Shares held
- 2.65M
- +2.34M (+758.2%) vs. Q4 2023
- Total value
- $1.40M
- +$953.2K (+212.2%) vs. Q4 2023
- New holders
- 3
- 7 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RDHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 14 | $270.0K |
| Q1 2026 | 16 | $386.5K |
| Q4 2025 | 17 | $514.5K |
| Q3 2025 | 14 | $51.2K |
| Q2 2025 | 12 | $37.9K |
| Q1 2025 | 12 | $80.5K |
| Q4 2024 | 11 | $103.5K |
| Q3 2024 | 11 | $48.8K |
| Q2 2024 | 18 | $719.7K |
| Q1 2024 | 17 | $1.40M |
| Q4 2023 | 19 | $449.2K |
| Q3 2023 | 19 | $781.9K |
| Q2 2023 | 21 | $419.2K |
| Q1 2023 | 20 | $1.20M |
| Q4 2022 | 41 | $1.51M |
| Q3 2022 | 43 | $1.46M |
| Q2 2022 | 48 | $3.89M |
| Q1 2022 | 49 | $11.9M |
| Q4 2021 | 57 | $12.5M |
| Q3 2021 | 61 | $24.5M |
| Q2 2021 | 55 | $49.1M |
| Q1 2021 | 64 | $77.4M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding RedHill Biopharma Ltd.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 189 | $0 | 0.00% | +47+33.1% | Added |
| IFP Advisors, Inc | 7 | $4 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 11 | $6 | 0.00% | +3+37.5% | Added |
| Wells Fargo & Company | 23 | $12 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 104 | $55 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 182 | $96 | 0.00% | +100+122.0% | Added |
| Aspire Private Capital, LLC | 406 | $215 | 0.00% | +1+0.2% | Added |
| Morgan Stanley | 516 | $274 | 0.00% | −60−10.4% | Reduced |
| Group One Trading, L.P. | 615 | $323 | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,550 | $6.12K | 0.00% | +11,550 | New |
| We Are One Seven, LLC | 15,750 | $8.35K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 21,175 | $11.0K | 0.00% | +21,175 | New |
| Rhumbline Advisers | 30,187 | $15.9K | 0.00% | −4,660−13.4% | Reduced |
| UBS Group AG | 50,592 | $26.8K | 0.00% | +50,488+48,546.2% | Added |
| Federation des caisses Desjardins du Quebec | 78,357 | $41.5K | 0.00% | +10,155+14.9% | Added |
| Gagnon Securities LLC | 118,360 | $62.7K | 0.01% | +28,771+32.1% | Added |
| Sabby Management, LLC | 2,319,238 | $1.23M | 8.04% | +2,319,238 | New |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −86,812−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −10,947−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Atlantic Edge Private Wealth Management, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |